ORLANDO, Fla. - Chemotherapy, a life-saving treatment for cancer patients, can come with side-effects, including trouble with attention, focus, tiredness, and memory recall. It's what doctors call ...

He’s been in the lab working on the problem of ‘Doxorubicin’ since his post-doc days at Stanford University, and at the Oklahoma Medical Research Foundation for a good part of that.

Patients age ≤ 40 years randomly received regimens with the same cumulative doses of drugs (ADM 420 mg/m 2, MTX 120 g/m 2, CDP 600 mg/m 2, and IFO 30 g/m 2) but with different durations (arm A, 44 ...

Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28 . JCO 23 , 3686-3696 (2005). DOI: 10.1200/JCO.2005.10.517 ...

According to the National Cancer Institute, Adriamycin is a chemotherapy drug that blocks an enzyme required for cell division and DNA repair. READ MORE: ‘Promising’ Treatments Identified for Older ...

British Journal of Cancer - Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? Skip to main content Thank you for visiting nature.com.